Immune restoration diseases reflect diverse immunopathological mechanisms

Clinical Microbiology Reviews

Volumn 22, Issue 4, 2009, Pages 651-663

  Price, Patricia ^a   Murdoch, David M ^b   Agarwal, Upasna ^c   Lewin, Sharon R ^d   Elliott, Julian H ^d   French, Martyn A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c LRS Institute of Tuberculosis and Respiratory Diseases   (India)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CYTOKINE; EMTRICITABINE; FLUCONAZOLE; FUNGUS ANTIGEN; LAMIVUDINE; PREDNISOLONE; TENOFOVIR; TUBERCULOSTATIC AGENT;

CHRONIC PENIS INFLAMMATION; CLINICAL TRIAL; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; ENCEPHALOMYELITIS; HEPATITIS B; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PENIS DISEASE; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETINITIS; REVIEW; SIDE EFFECT; SYMPTOM; TUBERCULOSIS; VIRUS INFECTION;

HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;

EID: 70449112958     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00015-09     Document Type: Review

References (159)

1. Aldeen, T., P. Hay, F. Davidson, and R. Lau. 1998. Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy. AIDS 12:1719-1720. (Pubitemid 28418346)
2. Almeida, M., M. Cordero, J. Almeida, and A. Orfao. 2007. Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection. Curr. HIV Res. 5:325-336.
3. Alspaugh, J. A., J. R. Perfect, and J. Heitman. 1997. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 11:3206-3217.
4. Antinori, S., A. Ridolfo, M. Fasan, C. Magni, L. Galimberti, L. Milazzo, S. Sollima, F. Adorni, G. Giuliani, M. Galli, M. Corbellino, and C. Parravicini. 2009. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy. HIV Med. 10:6-11.
5. Aranzabal, L., J. L. Casado, J. Moya, C. Quereda, S. Diz, A. Moreno, L. Moreno, A. Antela, M. J. Perez-Elias, F. Dronda, A. Marín, F. Hernandez-Ranz, A. Moreno, and S. Moreno. 2005. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin. Infect. Dis. 40:588-593.
6. Babu, C. K., K. Suwansrinon, G. D. Bren, A. D. Badley, and S. A. Rizza. 2009. HIV induces TRAIL sensitivity in hepatocytes. PLoS One 4:e4623.
7. Benhamou, Y. 2007. Hepatitis B in the HIV-coinfected patient. J. Acquir. Immune Defic. Syndr. 45:S57-S65.
8. Boelaert, J. R., K. H. Goddeeris, L. J. Vanopdenbosch, and J. W. Casselman. 2004. Relapsing meningitis caused by persistent cryptococcal antigens and immune reconstitution after the initiation of highly active antiretroviral therapy. AIDS 18:1223-1224.
9. Bourgarit, A., G. Carcelain, V. Martinez, C. Lascoux, V. Delcey, B. Gicquel, E. Vicaut, P. H. Lagrange, D. Sereni, and B. Autran. 2006. Explosion of tuberculin-specific Th1-responses induced immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20:F1-F7.
10. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J. M. Reynes, and A. E. Goldfeld. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Investig. 105:1317-1325.
11. Breen, R. A., C. J. Smith, H. Bettinson, S. Dart, B. Bannister, M. A. Johnson, and M. C. Lipman. 2004. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 59:704-707. (Pubitemid 39061536)
12. Breen, R. A., R. F. Miller, T. Gorsuch, C. J. Smith, J. Ainsworth, J. Ballinger, L. Swaden, I. Cropley, M. A. Johnson, and M. C. Lipman. 2006. Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J. Infect. Dis. 193:1437-1440.
13. Breton, G., X. Duval, C. Estellat, X. Poaletti, D. Bonnet, D. Mvondo Mvondo, P. Longuet, C. Leport, and J. L. Vilde. 2004. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin. Infect. Dis. 39:1709-1712.
14. Breton, G., H. Adle-Biassette, A. Therby, J. Ramanoelina, L. Choudat, F. Bissuel, M. Huerre, F. Dromer, B. Dupont, and O. Lortholary. 2006. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20:119-121. (Pubitemid 41818123)
15. Burman, W., S. Weis, A. Vernon, A. Khan, D. Benator, B. Jones, C. Silva, B. King, C. LaHart, B. Mangura, M. Weiner, and W. El-Sadr. 2007. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int. J. Tuberc. Lung Dis. 11:1282-1289.
16. Burman, W. J., and B. E. Jones. 2001. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am. J. Respir. Crit. Care Med. 164:7-12.
17. Campbell, I. A., and A. J. Dyson. 1977. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle 58:171-179. (Pubitemid 8247013)
18. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, DC.
19. Casado, J. L., J. Arrizabalaga, M. Montes, P. Martí-Belda, C. Tural, J. Pinilla, C. Gutierrez, J. Portu, R. Schuurman, K. Aguirrebengoa, et al. 1999. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. AIDS 13:1497-1502.
20. Chang, C. C., C. McLean, O. Vujovic, A. J. Jenney, M. Short, S. Lyon, E. Storey, and S. R. Lewin. 2009. Fatal acute varicella-zoster virus hemorrhagic meningomyelitis with necrotizing vasculitis in an HIV-infected patient. Clin. Infect. Dis. 48:372-373.
21. Chang, J. J., and S. R. Lewin. 2007. Immunopathogenesis of hepatitis B virus infection. Immunol. Cell Biol. 85:16-23.
22. Chang, Y. C., and K. J. Kwon-Chung. 1998. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect. Immun. 66:2230-2236.
23. Chang, Y. C., L. A. Penoyer, and K. J. Kwon-Chung. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983.
24. + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J. Virol. 79:3038-3051.
25. Charlier, C., F. Chretien, M. Baudrimont, E. Mordelet, O. Lortholary, and F. Dromer. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am. J. Pathol. 166:421-422.
26. Cherniak, R., and J. B. Sundstrom. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
27. Chiou, S. H., J. H. Liu, W. M. Hsu, S. S. Chen, S. Y. Chang, L. J. Juan, J. C. Lin, Y. T. Yang, W. W. Wong, C. Y. Liu, Y. S. Lin, W. T. Liu, and C. W. Wu. 2001. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirusinduced apoptosis in human retina. J. Immunol. 167:4098-4103.
28. Cinque, P., S. Bossolasco, A. M. Brambilla, A. Boschini, C. Mussini, C. Pierotti, A. Campi, S. Casari, D. Bertelli, M. Mena, and A. Lazzarin. 2003. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J. Neurovirol. 9(Suppl. 1):73-80. (Pubitemid 36656475)
29. Clark, B. M., R. G. Krueger, P. Price, and M. A. French. 2004. Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis. AIDS 18:1218-1221.
30. Colebunders, R., L. John, V. Huyst, A. Kambugu, F. Scano, and L. Lynen. 2006. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. Int. J. Tuberc. Lung Dis. 10:946-953.
31. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449. (Pubitemid 29205480)
32. Corbett, E. L., C. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-1021.
33. Crane, M., B. Oliver, G. Matthews, A. Avihingsanon, S. Ubolyam, V. Markovska, J. J. Chang, G. J. Dore, P. Price, K. Visvanathan, M. French, K. Ruxrungtham, and S. R. Lewin. 2009. Immunopathogenesis of hepatic flare in HIV-hepatitis B virus (HBV) co-infected individuals following initiation of HBV-active antiretroviral therapy. J. Infect. Dis. 199:974-981.
34. Crump, J. A., M. J. Tyrer, S. J. Lloyd-Owen, L. Y. Han, M. C. Lipman, and M. A. Johnson. 1998. Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin. Infect. Dis. 26:1008-1009.
35. Dautremer, J., J. Pacanowski, P. M. Girard, V. Lalande, F. Sivignon, and J. L. Meynard. 2007. A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis. AIDS 21:381-394. (Pubitemid 46175055)
36. de Jong, B. C., D. M. Israelski, E. L. Corbett, and P. M. Small. 2004. Clinical management of tuberculosis in the context of HIV infection. Annu. Rev. Med. 55:283-301.
37. de la Barrera, S., M. Aleman, R. Musella, P. Schierloh, V. Pasquinelli, V. Garcia, E. Abbate, and C. Sasiain Mdel. 2004. IL-10 down-regulates co-stimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 138:128-138.
38. De Rosa, F. G., S. Audagnotto, O. Bargiacchi, S. Garazzino, D. Aguilar Marucco, L. Veronese, F. Canta, S. Bonora, A. Sinicco, and G. Di Perri. 2006. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. J. Infect. 53:e215-e218.
39. Dhasmana, D. J., K. Dheda, P. Ravn, R. J. Wilkinson, and G. Meintjes. 2008. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 68:191-208.
40. Domingo, P., O. H. Torres, J. Ris, and G. Vazquez. 2001. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am. J. Med. 110:605-609.
41. Drake, A., A. Mijch, and J. Sasadeusz. 2004. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART. Clin. Infect. Dis. 39:129-132.
42. Dunić, I., O. Djurković-Djaković, S. Vesić, S. Zerjav, and D. Jevtović. 2005. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors. Int. J. STD AIDS 16:475-478. (Pubitemid 41003147)
43. Dunn, C., M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, E. Humphreys, S. Afford, D. H. Adams, A. Bertoletti, and M. K. Maini. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204:667-680.
44. Elliott, A. M., W. S. Hodsdon, J. Kyosiimire, M. A. Quigley, J. S. Nakiyingi, P. B. Namujju, C. Watera, N. French, C. F. Gilks, H. M. Dockrell, and J. A. Whitworth. 2004. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans. R. Soc. Trop. Med. Hyg. 98:660-670.
45. Falasca, K., C. Ucciferri, M. Dalessandro, P. Zingariello, P. Mancino, C. Petrarca, E. Pizzigallo, P. Conti, and J. Vecchiet. 2006. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann. Clin. Lab. Sci. 36:144-150.
46. Falcó, V., M. Olmo, S. V. del Saz, A. Guelar, J. R. Santos, M. Gutiérrez, D. Colomer, E. Deig, G. Mateo, M. Montero, E. Pedrol, D. Podzamczer, P. Domingo, and J. M. Llibre. 2008. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J. Acquir. Immune Defic. Syndr. 49:26-31.
47. Filippini, P., N. Coppola, R. Pisapia, C. Scolastico, C. Marrocco, A. Zaccariello, C. Nacca, C. Sagnelli, G. De Stefano, T. Ferraro, C. De Stefano, and E. Sagnelli. 2006. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS 20:1253-1260. (Pubitemid 44030373)
48. Fox, P. A., S. E. Barton, N. Francis, M. Youle, D. C. Henderson, D. Pillay, M. A. Johnson, L. Fearfield, B. G. Gazzard, and C. B. Bunker. 1999. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med. 1:10-18.
49. + regulatory T cells in patients with hepatitis B virus infection. J. Virol. 79:3322-3328.
50. French, M. A., S. A. Mallal, and R. L. Dawkins. 1992. Zidovudine-induced restoration of cellular immunity to mycobacteria in immunodeficient HIV-infected patients treated with zidovudine. AIDS 6:1293-1297.
51. French, M. A., N. Lenzo, M. John, S. A. Mallal, E. J. McKinnon, I. R. James, P. Price, J. P. Flexman, and M. L. Tay-Kearney. 2000. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 1:107-115.
52. French, M. A., P. Price, and S. F. Stone. 2004. Immune restoration disease after antiretroviral therapy. AIDS 18:1615-1627. (Pubitemid 39095778)
53. French, M. A. 2009. Immune reconstitution inflammatory syndrome: a reappraisal. Clin. Infect. Dis. 48:101-107.
54. Gasnault, J., M. Kahraman, M. G. de Goër de Herve, D. Durali, J. F. Delfraissy, and Y. Taoufik. 2003. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 17:1443-1449. (Pubitemid 36900544)
55. Gavazzi, G., O. Bouchard, P. Leclercq, C. Morel-Baccard, A. Bosseray, N. Dutertre, M. Micoud, and P. Morand. 2000. Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders? AIDS Res. Hum. Retrovir. 16:1021-1023.
56. Graybill, J. R., J. Sobel, M. Saag, C. van der Horst, W. Powderly, G. Cloud, L. Riser, R. Hamill, W. Dismukes, et al. 2000. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin. Infect. Dis. 30:47-54.
57. Gruner, N. H., T. J. Gerlach, M. C. Jung, H. M. Diepolder, C. A. Schirren, W. W. Schraut, R. Hoffmann, R. Zachoval, T. Santantonio, M. Cucchiarini, A. Cerny, and G. R. Pape. 2000. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J. Infect. Dis. 181:1528-1536.
58. Guex, A. C., H. C. Bucher, N. Demartines, U. Fluckiger, and M. Battegay. 2002. Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case. Dis. Colon Rectum 45:977-978.
59. Haubrich, R. H., D. Haghighat, S. A. Bozzette, J. Tilles, J. A. McCutchan, et al. 1994. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. J. Infect. Dis. 170: 238-242.
60. Hsieh, S. M., S. C. Pan, C. C. Hung, H. C. Tsai, M. Y. Chen, and S. C. Chang. 2001. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. J. Infect. Dis. 184:1386-1391.
61. Huruy, K., A. Mulu, G. Mengistu, A. Shewa-Amare, A. Akalu, A. Kassu, G. Andargie, D. Elias, and W. Torben. 2008. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. Jpn. J. Infect. Dis. 61:205-209.
62. Huyst, V., L. Lynen, E. Bottieau, M. Zolfo, L. Kestens, and R. Colebunders. 2007. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin. Belg. 62:126-129.
63. John, M., and M. A. French. 1998. Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy. Med. J. Aust. 169:473-474.
64. John, M., J. Flexman, and M. A. French. 1998. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS 12:2289-2293.
65. Johnson, S. C., C. A. Benson, D. W. Johnson, and A. Weinberg. 2001. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution. Clin. Infect. Dis. 32:815-819.
66. Jones, B. E., S. M. Young, D. Antoniskis, P. T. Davidson, F. Kramer, and P. F. Barnes. 1993. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 148:1292-1297.
67. Kambugu, A., D. B. Meya, J. Rhein, M. O'Brien, E. N. Janoff, A. R. Ronald, M. R. Kamya, H. Mayanja-Kizza, M. A. Sande, P. R. Bohjanen, and D. R. Boulware. 2008. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin. Infect. Dis. 46:1694-1701.
68. Kestens, L., N. Seddiki, and P. Bohjanen. 2008. Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy. Curr. Opin. HIV AIDS 3:419-424.
69. King, M. D., C. A. Perlino, J. Cinnamon, and J. A. Jernigan. 2002. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. Int. J. STD AIDS 13:724-726.
70. Kozel, T. R., and J. Cazin. 1971. Nonencapsulated variant of Cryptococcus neoformans. I. Virulence studies and characterization of soluble polysaccharide. Infect. Immun. 3:287-294.
71. Kumarasamy, N., S. Chaguturu, K. H. Mayer, S. Solomon, H. T. Yepthomi, P. Balakrishnan, and T. P. Flanigan. 2004. Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J. Acquir. Immune Defic. Syndr. 37:1574-1576.
72. Labarga, P., V. Soriano, M. E. Vispo, J. Pinilla, L. Martin-Carbonero, C. Castellares, R. Casado, I. Maida, P. Garcia-Gasco, and P. Barreiro. 2007. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients. J. Infect. Dis. 196:670-676.
73. Larrubia, J. R., M. Calvino, S. Benito, E. Sanz-de-Villalobos, C. Perna, J. Pérez-Hornedo, F. González-Mateos, S. García- Garzón, A. Bienvenido, and T. Parra. 2007. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection. J. Hepatol. 47:632-641.
74. Larsen, R. A., M. A. Leal, and L. S. Chan. 1990. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann. Intern. Med. 113:183-187.
75. Lascar, R. M., R. J. Gilson, A. R. Lopes, A. Bertoletti, and M. K. Maini. 2003. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection. J. Infect. Dis. 188:1815-1819.
76. Lascar, R. M., A. R. Lopes, R. J. Gilson, C. Dunn, R. Johnstone, A. Copas, S. Reignat, G. Webster, A. Bertoletti, and M. K. Maini. 2005. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection. J. Infect. Dis. 191:1169-1179.
77. Lawn, S. D., L. Myer, L. G. Bekker, and R. G. Wood. 2007. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21:335-341.
78. Lawn, S. D., L. Myer, G. Harling, C. Orrell, L. G. Bekker, and R. Wood. 2006. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin. Infect. Dis. 43:770-776.
79. Lawn, S. D., and D. C. Macallan. 2004. Hypercalcemia: a manifestation of immune reconstitution complicating tuberculosis in an HIV-infected person. Clin. Infect. Dis. 38:154-155.
80. Lawn, S. D., H. Wainwright, and C. Orrell. 2009. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 23:143-145.
81. Lawn, S. D., L. G. Bekker, L. Myer, C. Orrell, and R. Wood. 2005. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 19:2050-2052.
82. Lim, A. F. Y., L. D'Orsogna, P. Price, and M. French. 2008. Imbalance effector and regulatory cytokine responses may underlie mycobacterial immune restoration disease. AIDS Res. Ther. 5:9.
83. Lok, A. S., and B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45:507-539.
84. Lortholary, O., A. Fontanet, N. Memain, A. Martin, K. Sitbon, and F. Dromer. 2005. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19:1043-1049. (Pubitemid 40961144)
85. Maini, M. K., C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, R. Williams, D. Vergani, N. V. Naoumov, C. Ferrari, and A. Bertoletti. 2000. The role of virus-specific CD8 cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280.
86. Mallal, S. A., I. R. James, and M. A. French. 1994. Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine. AIDS 8:1263-1269.
87. Manabe, Y. C., J. D. Campbell, E. Sydnor, and R. D. Moore. 2007. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J. Acquir. Immune Defic. Syndr. 46:456-462.
88. Manosuthi, W., S. Kiertiburanakul, T. Phoorisri, and S. Sungkanuparph. 2006. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. J. Infect. 53:357-363. (Pubitemid 44688983)
89. Manosuthi, W., S. Kiertiburanakul, S. Sungkanuparph, K. Ruxrungtham, A. Vibhagool, S. Rattanasiri, and A. Thakkinstian. 2006. Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results. AIDS 20:131-132. (Pubitemid 41818129)
90. Martínez, E., J. Gatell, Y. Morán, E. Aznar, E. Buira, A. Guelar, J. Mallolas, and E. Soriano. 1998. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin. Infect. Dis. 27:1510-1513.
91. Matthews, G. V., A. Avihingsanon, S. R. Lewin, J. Amin, R. Rerknimitr, P. Petcharapirat, P. Marks, J. Sasadeusz, D. A. Cooper, S. Bowden, S. Locarnini, K. Ruxrungtham, and G. J. Dore. 2008. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand. Hepatology 48:1062-1069.
92. Mazzarino, P., G. Pietra, P. Vacca, M. Falco, D. Colau, P. Coulie, L. Moretta, and M. C. Mingari. 2005. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur. J. Immunol. 35:3240-3247.
93. Meintjes, G., S. D. Lawn, G. Scano, F. Maartens, M. A. French, W. Worodria, J. H. Elliott, D. Murdoch, R. J. Wilkinson, C. Seyler, L. John, M. S. van der Loeff, P. Reiss, L. Lynen, E. N. Janoff, R. Gilks, C. Colebunders, and International Network for the Study of HIV-associated IRIS. 2008. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect. Dis. 8:516-523.
94. Meintjes, G., K. A. Wilkinson, M. X. Rangaka, K. Skolimowska, K. van Veen, M. Abrahams, R. Seldon, D. J. Pepper, K. Rebe, P. Mouton, G. van Cutsem, M. P. Nicol, G. Maartens, and R. J. Wilkinson. 2008. Th1 and FoxP3 positive T cells and the HIV-tuberculosis immune reconstitution inflammatory syndrome. Am. J. Respir. Crit. Care Med. 178:1083-1089.
95. Meintjes, G., R. Wilkinson, C. Morroni, D. Pepper, K. Rebe, M. Rangaka, T. Oni, and G. Maartens. 2009. Randomized placebo-controlled trial of prednisone for the TB immune reconstitution inflammatory syndrome, abstr. 34. Abstr. 16th Conf. Retrovir. Opportun. Infect., Montreal, Canada, February 2009.
96. Menichetti, F., M. Fiorio, A. Tosti, G. Gatti, M. B. Pasticci, F. Miletich, M. Marroni, D. Bassetti, and S. Pauluzzi. 1996. High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 22:838-840.
97. Miailhes, P., M. A. Trabaud, P. Pradat, B. Lebouché, M. Chevallier, P. Chevallier, F. Zoulim, and C. Trepo. 2007. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion. Clin. Infect. Dis. 45:624-632.
98. Miralles, P., J. Berenguer, C. Lacruz, J. Cosín, J. C. López, B. Padilla, L. Munoz, and D. García-de-Viedma. 2001. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15:1900-1902. (Pubitemid 32939260)
99. Murdoch, D. M., W. D. F. Venter, C. Feldman, and A. V. Rie. 2008. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22:601-610.
100. Murdoch, D. M., W. D. F. Venter, A. V. Rie, and C. Feldman. 2007. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res. Ther. 4:9.
101. Mutimer, H. P., Y. Akatsuka, T. Manley, E. L. Chuang, M. Boeckh, R. Harrington, T. Jones, and S. R. Riddell. 2002. Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J. Infect. Dis. 186:701-705.
102. Narita, M., D. Ashkin, E. S. Hollender, and A. E. Pitchenik. 1998. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am. J. Respir. Crit. Care Med. 158:157-161.
103. Ofotokun, I., S. E. Smithson, C. Lu, K. A. Easley, and J. L. Lennox. 2007. Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. Am. J. Med. Sci. 334:334-341.
104. Patel, A., K. Patel, J. Patel, N. Shah, B. Patel, and S. Rani. 2004. Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1. J. Acquir. Immune Defic. Syndr. 37:1166-1169.
105. Perez-Olmeda, M., J. Garcia-Samaniego, and V. Soriano. 2000. Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy. AIDS 14:212. (Pubitemid 30116453)
106. Perfect, J. R., and A. Casadevall. 2002. Cryptococcosis. Infect. Dis. Clin. N. Am. 16:837-874.
107. Peters, M. G., J. Andersen, P. Lynch, T. Liu, B. Alston-Smith, C. L. Brosgart, J. M. Jacobson, V. A. Johnson, R. B. Pollard, J. F. Rooney, K. E. Sherman, S. Swindells, B. Polsky, et al. 2006. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology 44:1110-1116.
108. Phillips, P., S. Bonner, N. Gataric, T. Bai, P. Wilcox, R. Hogg, M. O'Shaughnessy, and J. Montaner. 2005. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin. Infect. Dis. 41:1483-1497.
109. Pogany, K., H. L. Zaaijer, J. M. Prins, F. W. Wit, J. M. Lange, and M. G. Beld. 2005. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients. AIDS Res. Hum. Retrovir. 21:922-926.
110. Posada-Vergara, M. P., J. A. Lindoso, J. E. Tolezano, V. L. Pereira-Chioccola, M. V. Silva, and H. Goto. 2005. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J. Infect. Dis. 192:1819-1822.
111. Price, P., N. M. Keane, S. Lee, A. F. Lim, E. J. McKinnon, and M. A. French. 2006. A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy. Immunology 119:74-82. (Pubitemid 44201157)
112. Price, P., C. Witt, D. deSantis, and M. A. French. 2007. Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J. Acquir. Immune Defic. Syndr. 45:359-361.
113. Price, P., G. Morahan, D. Huang, E. Stone, K. Y. Cheong, A. Castley, M. Rogers, M. Q. McIntyre, L. J. Abraham, and M. A. French. 2002. Polymorphisms in cytokine genes define sub-populations of HIV-1 patients who experienced immune restoration diseases. AIDS 16:2043-2047. (Pubitemid 35205268)
114. Price, P., N. K. Keane, S. F. Stone, K. Y. M. Cheong, and M. A. H. French. 2001. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum. Immunol. 62:157-164.
115. Price, P., S. Fernandez, D. B. A. Tan, I. R. James, N. M. Keane, and M. A. French. 2008. Nadir CD4 T-cell counts continue to influence interferon-γ responses in HIV patients who began antiretroviral treatment with advanced immunodeficiency. J. Acquir. Immune Defic. Syndr. 49:462-464.
116. Puthanakit, T., P. Oberdorfer, N. Akarathum, P. Wannarit, T. Sirisanthana, and V. Sirisanthana. 2006. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children. Pediatr. Infect. Dis. J. 25:53-58.
117. Ramaswamy, M., A. Waters, C. Smith, E. Hainsworth, G. Hardy, M. Johnson, J. Ainsworth, A. Phillips, and A. M. Geretti. 2007. Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 195:410-415.
118. Ramdas, K., and G. Y. Minamoto. 1994. Paradoxical presentation of intracranial tuberculomas after chemotherapy in a patient with AIDS. Clin. Infect. Dis. 19:793-794.
119. Rapose, A., B. Sarvat, and J. C. Sarria. 2008. Immune reconstitution inflammatory syndrome presenting as pericarditis and pericardial effusion. Cardiology 110:142-144. (Pubitemid 351630041)
120. Ratnam, I., C. Chiu, N. B. Kandala, and P. J. Easterbrook. 2006. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin. Infect. Dis. 42:418-427.
121. Reddy, V., and G. A. Luzzi. 2005. Chronic vulval ulceration-another immune reconstitution inflammatory syndrome? Int. J. STD AIDS 16:454-455. (Pubitemid 40868387)
122. Richardson, D., L. Rubinstein, E. Ross, A. Rice, A. R. Wright, O. M. Kon, and J. Walsh. 2005. Cystic lung lesions as an immune reconstitution inflammatory syndrome (IRIS) in HIV-TB co-infection. Thorax 60:884. (Pubitemid 41475223)
123. Roe, B., S. Coughlan, J. Hassan, A. Grogan, G. Farrell, S. Norris, C. Bergin, and W. W. Hall. 2007. Elevated serum levels of interferon-gammainducible protein-10 in patients co-infected with hepatitis C virus and HIV. J. Infect. Dis. 196:1053-1057.
124. Saag, M. S., R. J. Graybill, R. A. Larsen, P. G. Pappas, J. R. Perfect, W. G. Powderly, J. D. Sobel, and W. E. Dismukes. 2000. Practice guidelines for the management of cryptococcal disease. Clin. Infect. Dis. 30:710-718.
125. Schiffer, J. T., and T. R. Sterling. 2007. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J. Acquir. Immune Defic. Syndr. 44:229-234.
126. Schrier, R. D., M. K. Song, I. L. Smith, M. P. Karavellas, D. U. Bartsch, F. J. Torriani, C. R. Garcia, and W. R. Freeman. 2006. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis. Retina 26:165-169.
127. Seddiki, N., S. C. Sasson, B. Santner-Nanan, M. Munier, D. van Bockel, S. Ip, D. Marriott, S. Pett, R. Nanan, D. A. Cooper, J. J. Zaunders, and A. D. Kelleher. 2009. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur. J. Immunol. 39:391-403.
128. Serra, F. C., D. Hadad, R. L. Orofino, F. Marinho, C. Lourenco, M. Morgado, and V. Rolla. 2007. Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro. Braz. J. Infect. Dis. 11:462-465.
129. Shelburne, S. A., F. Visnegarwala, J. Darcourt, E. A. Graviss, T. P. Giordano, A. C. White, and R. J. Hamill. 2005. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19:399-406. (Pubitemid 40446186)
130. Shelburne, S. A., J. Darcourt, A. C. White, Jr., S. B. Greenberg, R. J. Hamill, R. L. Atmar, and F. Visnegarwala. 2005. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 40:1049-1052.
131. Shoham, S., C. Huang, J. M. Chen, D. T. Golenbock, and S. M. Levitz. 2001. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166:4620-4626.
132. Sprengers, D., R. G. van der Molen, J. G. Kusters, B. Hansen, H. G.
133. Stone, S. F., P. Price, M.-L. Tay-Kearney, and M. A. French. 2002. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during HAART-induced restoration of CMV-specific immune responses within a predominant T2 cytokine environment. J. Infect. Dis. 185:1813-1817.
134. Stone, S. F., P. Price, J. Brochier, and M. French. 2001. Plasma bioavailable IL-6 is increased in HIV patients who experienced herpes-associated immune restoration disease after commencing HAART. J. Infect. Dis. 184:1073-1078.
135. Stone, S. F., S. Lee, N. M. Keane, P. Price, and M. A. French. 2002. Hepatotoxicity after HAART in HIV/HCV co-infected patients is associated with increased HCV-specific IgG and sCD26 (DPP IV) enzyme activity. J. Infect. Dis. 186:1498-1502.
136. Subhash, H. S., S. Supriya, B. Prakash, and K. Thomas. 2006. Acute respiratory distress syndrome as a paradoxical response to anti-tuberculosis and anti-retroviral therapy. Indian J. Tuberc. 53:157-160.
137. Sungkanuparph, S., U. Jongwutiwes, and S. Kiertiburanakul. 2007. Timing of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. J. Acquir. Immune Defic. Syndr. 45:595-596.
138. Tan, D. B., Y. K. Yong, H. Y. Tan, A. Kamarulzaman, L. H. Tan, A. Lim, I. James, M. French, and P. Price. 2008. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 9:307-316.
139. Tan, K., R. Roda, L. Ostrow, J. McArthur, and A. Nath. 2009. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72:1458-1464.
140. Tangsinmankong, N., W. Kamchaisatian, J. Lujan-Zilbermann, C. L. Brown, J. W. Sleasman, and P. J. Emmanuel. 2004. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J. Allergy Clin. Immunol. 113:742-746.
141. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809-1814.
142. Thimme, R., J. Bukh, H. C. Spangenberg, S. Wieland, J. Pemberton, C. Steiger, S. Govindarajan, R. H. Purcell, and F. V. Chisari. 2002. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 99:15661-15668.
143. Torti, C., G. Lapadula, M. Puoti, S. Casari, M. C. Uccelli, G. Cristini, D. Bella, G. Pastore, N. Ladisa, L. Minoli, G. Sotgiu, S. L. Caputo, S. Bonora, and G. Carosi. 2006. Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER cohort. J. Acquir. Immune Defic. Syndr. 41:180-185.
144. Vali, B., F. Yue, R. Jones, P. M. Sheth, R. Kaul, M. R. Betts, D. Wong, C. Kovacs, M. Loutfy, A. Common, R. Halpenny, and M. A. Ostrowski. 2008. HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection. PLoS One 3:3454.
145. Van den Bergh, R., G. Vanham, G. Raes, P. De Baetselier, and R. Colebunders. 2006. Mycobacterium-associated immune reconstitution disease: macrophages running wild? Lancet Infect. Dis. 6:2-3.
146. Vendrely, A., B. Bienvenu, J. Gasnault, J. B. Thiebault, D. Salmon, and F. Gray. 2005. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multi-focal leukoencephalopathy. Acta Neuropathol. 109:449-455. (Pubitemid 40637320)
147. Vento, S., T. Garofano, C. Renzini, F. Casali, T. Ferraro, and E. Concia. 1998. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS 12:116-117. (Pubitemid 28021325)
148. Vidal, J. E., S. Cimerman, R. Schiavon Nogueira, F. Bonasser Filho, J. Sztajnbok, P. R. da Silva, D. L. Lins, and J. F. Coelho. 2003. Paradoxical reaction during treatment of tuberculous brain abscess in a patient with AIDS. Rev. Inst. Med. Trop. Sao Paulo 45:177-178.
149. Wendel, K. A., K. S. Alwood, R. Gachuhi, R. E. Chaisson, W. R. Bishai, and T. R. Sterling. 2001. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120:193-197. (Pubitemid 32744878)
150. Wilkinson, G. W., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, S. Llewellyn-Lacey, E. C. Wang, C. A. Griffin, and A. J. Davison. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41:206-212.
151. Wiselka, M. J., K. G. Nicholson, S. Rowley, and K. Bibby. 1999. Cytomegalovirus viraemia has poor predictive value for the development of cytomegalovirus disease in patients with advanced HIV-infection. J. Infect. 39:187-192.
152. Woods, M. L., II, R. MacGinley, D. P. Eisen, and A. M. Allworth. 1998. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12:1491-1494.
153. World Health Organization. 2006. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access, p.58-61. WHO Press, Geneva, Switzerland.
154. Yauch, L. E., J. S. Lam, and S. M. Levitz. 2006. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2:e120.
155. York, J., I. Bodi, I. Reeves, P. Riordan-Eva, and P. J. Easterbrook. 2005. Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease? J. Infect. 51:165-171. (Pubitemid 40984353)
156. Yudin, M. H., and R. Kaul. 4 September 2008, posting date. Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy. Infect. Dis. Obstet. Gynecol. doi: 10.1155/2008/592532.
157. Zeitoun, J. D., V. Mallet, M. L. Chaix, J. P. Viard, S. Blanche, and S. Pol. 2007. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. J. Clin. Virol. 40:71-73.
158. Zolopa, A., J. Andersen, W. Powderly, A. Sanchez, I. Sanne, C. Suckow, E. Hogg, and L. Komarow. 2009. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 4:e5575.
159. Zylberberg, H., M. L. Chaix, C. Rabian, C. Rouzioux, B. Aulong, C. Bré- chot, J. P. Viard, and S. Pol. 1998. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects. Clin. Infect. Dis. 26:1104-1106.